Smart-Money SignalDistribution · 21/100— Insiders are net sellers over 90 days (-$120M, 32 sales vs 14 buys)
Revenue$2.5M
Net Income$303.0M
EPS$-0.54
Market Cap$26.2B
Price Performance
Historical data including institutional events
Company Profile
M
Matt Gline
CEO & Executive Director
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.